Statins and Preeclampsia Prevention: Yes or No.  episode artwork

EPISODE · Mar 3, 2022 · 16 MIN

Statins and Preeclampsia Prevention: Yes or No.

from Dr. Chapa’s OBGYN Clinical Pearls · host Dr. Chapa’s Clinical Pearls

Preeclampsia occurs in 3 to 5% of the general OB population. It has even higher prevalence among those with high-risk conditions. Currently, aspirin stands alone as the most evidence-based pharmacological option for preeclampsia prevention (risk reduction). But over the last decade new interest has arisen for the use of statins for preeclampsia prevention. Well, do statins work? What is the state of statin therapy as of 2022? In this session we will review the latest data and review the key pathogenesis in preeclampsia formation.

Episode metadata supplied by the publisher feed · Published Mar 3, 2022

Embed this episode

NOW PLAYING

Statins and Preeclampsia Prevention: Yes or No.

0:00 16:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr. Chapa’s OBGYN Clinical Pearls?

This episode is 16 minutes long.

When was this Dr. Chapa’s OBGYN Clinical Pearls episode published?

This episode was published on March 3, 2022.

Can I download this Dr. Chapa’s OBGYN Clinical Pearls episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!